Profit & Loss

Cipla Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	500087	NSE Symbol:	CIPLA	P/E :	25.02
ISIN Demat:	INE059A01026	Div & Yield %:	1.07	EPS :	59.59
Book Value:	397.39	Market Cap (Rs. Cr.):	120,427.63	Face Value :	2

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
INCOME :	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Sales Turnover	19,044.85	16,574.34	14,345.34	15,380.82	11,302.71	12,659.15
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	19,044.85	16,574.34	14,345.34	15,380.82	11,302.71	12,659.15
Other Income	1,279.38	1,433.72	826.20	742.05	653.91	892.85
Stock Adjustments	229.87	-104.57	-194.32	541.93	-6.41	43.08
Total Income	20,554.10	17,903.49	14,977.22	16,664.80	11,950.21	13,595.08
EXPENDITURE :	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Raw Materials	5,699.59	4,977.62	4,739.89	6,467.54	4,097.20	4,362.29
Power & Fuel Cost	290.24	271.66	257.07	247.58	234.58	253.95
Employee Cost	3,054.87	2,688.51	2,380.68	2,122.02	1,703.58	1,911.08
Other Manufacturing Expenses	1,374.94	997.59	710.80	994.55	906.09	921.04
Selling & Administrative Expenses	2,604.73	2,510.53	2,334.97	2,107.17	1,578.59	2,093.92
Miscellaneous Expenses	471.91	539.71	560.62	272.66	-291.15	452.66
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	13,496.28	11,985.62	10,984.03	12,211.52	8,228.89	9,994.94
Operating Profit	7,057.82	5,917.87	3,993.19	4,453.28	3,721.32	3,600.14
Interest	15.11	20.25	22.27	26.93	45.07	36.05
Gross Profit	7,042.71	5,897.62	3,970.92	4,426.35	3,676.25	3,564.09
Depreciation	573.89	587.59	595.91	546.62	468.62	599.78
Profit Before Tax	6,468.82	5,310.03	3,375.01	3,879.73	3,207.63	2,964.31
Tax	1,360.32	1,226.69	901.63	949.49	756.27	545.96
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-49.15	6.09	-40.09	-27.69	-16.92	100.18
Reported Net Profit	5,157.65	4,077.25	2,513.47	2,957.93	2,468.28	2,318.17
Extraordinary Items	344.27	42.92	-41.59	48.88	39.09	91.40
Adjusted Net Profit	4,813.38	4,034.33	2,555.06	2,909.05	2,429.19	2,226.77
Adjustment below Net Profit	-12.96	-74.47	-10.52	18.48	13.71	-49.53
P & L Balance brought forward	22,950.83	19,634.22	17,534.77	14,961.71	12,479.72	10,828.56
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1,049.83	686.17	403.50	403.35	0.00	617.48
P & L Balance carried down	27,045.69	22,950.83	19,634.22	17,534.77	14,961.71	12,479.72
Dividend	0.00	0.00	0.00	0.00	0.00	322.49
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	800.00	650.00	425.00	250.00	250.00	200.00
Dividend Per Share(Rs)	16.00	13.00	8.50	5.00	5.00	4.00
Earnings Per Share-Unit Curr	63.86	50.50	31.14	36.66	30.61	28.75
Earnings Per Share(Adj)-Unit Curr	63.86	50.50	31.14	36.66	30.61	28.75
Book Value-Unit Curr	397.46	346.49	305.25	279.05	247.10	215.85
Book Value(Adj)-Unit Curr	397.46	346.49	305.25	279.05	247.10	215.85

Company Snapshot

Read it, Learn it and Do it for your investment Needs

Profit & Loss